BPSPrep

Syllabus

BCTXP Prep Course (BCTXP)

79 lessons. Online and self-paced.

Transplant Foundations

Core biology, organ failure states, and transplant process concepts that support medication-related decision-making throughout the exam.

  1. 1Kidney Failure Pharmacology Context
  2. 2Liver Failure Pharmacology Context
  3. 3Cardiopulmonary Failure Pharmacology Context
  4. 4Pancreas And Multi-Organ Context
  5. 5Alloimmunity And Histocompatibility
  6. 6Rejection Phenotypes And Timing
  7. 7Immunologic Risk Stratification
  8. 8Desensitization Pharmacotherapy Principles
  9. 9Candidate Evaluation Medication Issues
  10. 10Living Donor Medication Considerations
  11. 11Allocation Scores And Medication Implications
  12. 12Perioperative Complication Medication Support

Assessment And Planning

Patient assessment framework for pharmacotherapy planning, including PK/PD, diagnostics, pharmacogenomics, vaccines, and special populations.

  1. 13Medication History And Reconciliation
  2. 14Laboratory And Diagnostic Interpretation
  3. 15Allergy And Intolerance Assessment
  4. 16Calcineurin Inhibitor Pharmacokinetics
  5. 17Antimetabolite And MTOR Pharmacology
  6. 18Pharmacogenomics In Transplant Dosing
  7. 19Special Population PK Considerations
  8. 20Immunization Planning Across Transplant
  9. 21Social Determinants And Adherence Risk
  10. 22Patient Assistance And Access Planning

Immunosuppression Core

Foundational and advanced immunosuppressive therapy selection, implementation, and therapeutic monitoring for transplant recipients.

  1. 23Lymphocyte-Depleting Induction Agents
  2. 24IL-2 Receptor Antagonist Use
  3. 25Induction Selection By Risk
  4. 26Tacrolimus-Based Triple Therapy
  5. 27Cyclosporine-Based Regimen Design
  6. 28MTOR Conversion Strategies
  7. 29Belatacept And CNI Avoidance
  8. 30Tacrolimus Trough Interpretation
  9. 31Cyclosporine Concentration Monitoring
  10. 32MTOR Level And Toxicity Monitoring

Interactions And Toxicity

Drug interactions, formulation issues, and immunosuppressant toxicities frequently tested in transplant pharmacy scenarios.

  1. 33Azole And Macrolide Interactions
  2. 34Inducers And Subtherapeutic Exposure
  3. 35Food Formulation And Route Effects
  4. 36Complex Interaction Case Patterns
  5. 37CNI Nephrotoxicity And Neurotoxicity
  6. 38Antimetabolite GI And Marrow Toxicity
  7. 39MTOR Toxicity Syndromes
  8. 40Steroid Complication Mitigation
  9. 41Enteral And Feeding Tube Administration
  10. 42IV To Oral Conversion
  11. 43Adherence Packaging And Simplification

Infection Prevention

Transplant infectious prophylaxis, immunization timing, and early antimicrobial decision support within pharmacist scope.

  1. 44CMV Risk Stratification
  2. 45CMV Prophylaxis And Treatment Support
  3. 46BK And EBV Medication Implications
  4. 47PJP Prophylaxis Selection
  5. 48Antifungal Prophylaxis Strategies
  6. 49Opportunistic Infection Drug Traps
  7. 50Perioperative Antibacterial Prophylaxis
  8. 51Recipient Vaccine Counseling
  9. 52Post-Exposure Pharmacotherapy Planning

Rejection And Graft Dysfunction

Medication-related evaluation and management support for rejection, underimmunosuppression, and common causes of graft dysfunction.

  1. 53Cellular Rejection Treatment Support
  2. 54Antibody-Mediated Rejection Support
  3. 55Rejection Versus Drug Toxicity
  4. 56Chronic Allograft Injury Signals
  5. 57Nonadherence And Variable Exposure
  6. 58Protocol Variability And Safe Answers
  7. 59Kidney Graft Dysfunction Workup
  8. 60Liver Heart Lung Dysfunction Clues
  9. 61Pancreas And Multi-Organ Dysfunction

Organ-Specific Management

High-yield transplant pharmacotherapy distinctions across major organ programs and post-transplant comorbidities.

  1. 62Delayed Graft Function Support
  2. 63Recurrent Kidney Disease Medication Issues
  3. 64Pancreas Glycemic And Enzyme Monitoring
  4. 65Liver Transplant Drug Challenges
  5. 66Heart Transplant Vasculopathy Prevention
  6. 67Lung Transplant Infection Balance
  7. 68Hypertension Dyslipidemia And ASCVD
  8. 69Post-Transplant Diabetes Management
  9. 70Bone Health And Malignancy Prevention

Professional Practice

Quality, safety, regulations, ethics, insurance, research, and team-based practice through a transplant pharmacist lens.

  1. 71Guideline-Informed Transplant Decisions
  2. 72Medication Safety In Transitions
  3. 73Interprofessional Escalation And Scope
  4. 74Ethics And Patient Advocacy
  5. 75Insurance Formularies And Appeals
  6. 76Collaborative Practice And Documentation
  7. 77Trial Design And Endpoint Appraisal
  8. 78Biostatistics For Board Questions
  9. 79Education Of Learners And Patients
BPSPrep
Programs
For organizations
ContactLog inGet a free guide